navigating qtc prolonging potential of pharmacotherapies for covid-19
Published 4 years ago • 1.1K plays • Length 16:35Download video MP4
Download video MP3
Similar videos
-
1:00
mcp 60 seconds with dr michael ackerman on long qt & covid-19
-
50:04
how to mitigate drug-induced sudden cardiac death from hydroxychloroquine | full video
-
21:20
lessons learned: navigating the covid-19 pandemic
-
46:27
covid-19, arrhythmias and long qt
-
3:34
q&a on covid-19 from mayo clinic
-
19:33
covid-19 infection and vaccination: understanding the prothrombotic risk
-
4:55
hcq and qtc prolongation: dr david liew
-
18:25
testing and timing for covid-19 therapies: understanding factors for optimization
-
9:40
precision medicine and phenotyping
-
1:08:06
what clinicians need to know about therapeutic options for covid-19
-
14:29
episode 2: long-term care treatment options for covid-19
-
52:38
long covid: risk factors, symptomology and pros captured through a novel digital platform
-
55:54
covid-19 tracking and control measures | 2020 virtual summit
-
11:34
drugs increase qt interval || proarrhythmic agents
-
5:52
avoiding preanalytical problems in covid-19 testing
-
9:55
safety guideline for covid-19: vaccination and immunity
-
58:52
understanding testing to help manage the covid-19 pandemic
-
1:02:30
updated cdc covid-19 quarantine and isolation guidelines in healthcare and non-healthcare settings
-
32:25
covid-19 vaccine: expert q&a